CD63(+) Cancer‐Associated Fibroblasts Confer Tamoxifen Resistance to Breast Cancer Cells through Exosomal miR‐22

Tamoxifen remains the most effective treatment for estrogen receptor α (ERα)‐positive breast cancer. However, many patients still develop resistance to tamoxifen in association with metastatic recurrence, which presents a tremendous clinical challenge. To better understand tamoxifen resistance from...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Yuan, Li, Xiaoju, Zeng, Cheng, Liu, Chenlin, Hao, Qiang, Li, Weina, Zhang, Kuo, Zhang, Wangqian, Wang, Shuning, Zhao, Huadong, Fan, Dong, Li, Meng, Zhang, Yingqi, Zhang, Wei, Zhang, Cun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Full Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7610308/
https://www.ncbi.nlm.nih.gov/pubmed/33173749
http://dx.doi.org/10.1002/advs.202002518

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7610308/
https://www.ncbi.nlm.nih.gov/pubmed/33173749
http://dx.doi.org/10.1002/advs.202002518

Ejemplares similares